Conditions: Alzheimer Disease
Keywords: Amyloid imaging Positron Emission Tomography 18F-AV-45 florbetapir F 18 Diagnostic imaging
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 9
Healthy volunteers: yes

Brief summary:
This study will determine how florbetapir F 18 (18F-AV-45) radioactivity is distributed throughout the body.

Detailed description:

Arms:
arm 1: Healthy male or female subjects, between 18 and 85 years of age.

Interventions: intervention 1: florbetapir F 18
Intervention descriptions: intervention 1: IV injection, 370MBq (10mCi), single dose

Protocol document: